These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 26047945)
1. The chemokine receptor CCR6 facilitates the onset of mammary neoplasia in the MMTV-PyMT mouse model via recruitment of tumor-promoting macrophages. Boyle ST; Faulkner JW; McColl SR; Kochetkova M Mol Cancer; 2015 Jun; 14():115. PubMed ID: 26047945 [TBL] [Abstract][Full Text] [Related]
2. Haploid inactivation of the amplified-in-breast cancer 3 coactivator reduces the inhibitory effect of peroxisome proliferator-activated receptor gamma and retinoid X receptor on cell proliferation and accelerates polyoma middle-T antigen-induced mammary tumorigenesis in mice. Zhang H; Kuang SQ; Liao L; Zhou S; Xu J Cancer Res; 2004 Oct; 64(19):7169-77. PubMed ID: 15466215 [TBL] [Abstract][Full Text] [Related]
3. Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth. Mao SPH; Park M; Cabrera RM; Christin JR; Karagiannis GS; Oktay MH; Zaiss DMW; Abrams SI; Guo W; Condeelis JS; Kenny PA; Segall JE Breast Cancer Res; 2018 Oct; 20(1):131. PubMed ID: 30367629 [TBL] [Abstract][Full Text] [Related]
4. Deletion of Martínez-Nieto G; Heljasvaara R; Heikkinen A; Kaski HK; Devarajan R; Rinne O; Henriksson C; Thomson E; von Hertzen C; Miinalainen I; Ruotsalainen H; Pihlajaniemi T; Karppinen SM Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576139 [TBL] [Abstract][Full Text] [Related]
5. Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer. Miwa HE; Koba WR; Fine EJ; Giricz O; Kenny PA; Stanley P Glycobiology; 2013 Dec; 23(12):1477-90. PubMed ID: 24037315 [TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer. Schwab LP; Peacock DL; Majumdar D; Ingels JF; Jensen LC; Smith KD; Cushing RC; Seagroves TN Breast Cancer Res; 2012 Jan; 14(1):R6. PubMed ID: 22225988 [TBL] [Abstract][Full Text] [Related]
7. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966 [TBL] [Abstract][Full Text] [Related]
8. Early vascular deficits are correlated with delayed mammary tumorigenesis in the MMTV-PyMT transgenic mouse following genetic ablation of the NG2 proteoglycan. Gibby K; You WK; Kadoya K; Helgadottir H; Young LJ; Ellies LG; Chang Y; Cardiff RD; Stallcup WB Breast Cancer Res; 2012 Apr; 14(2):R67. PubMed ID: 22531600 [TBL] [Abstract][Full Text] [Related]
9. Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model. Otsuka Y; Oikawa T; Yoshino H; Hashimoto S; Handa H; Yamamoto H; Hashimoto A; Sabe H Cell Commun Signal; 2018 Jan; 16(1):1. PubMed ID: 29329590 [TBL] [Abstract][Full Text] [Related]
11. The chemokine receptor CCR7 promotes mammary tumorigenesis through amplification of stem-like cells. Boyle ST; Ingman WV; Poltavets V; Faulkner JW; Whitfield RJ; McColl SR; Kochetkova M Oncogene; 2016 Jan; 35(1):105-15. PubMed ID: 25772241 [TBL] [Abstract][Full Text] [Related]
12. Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models. Du Z; Podsypanina K; Huang S; McGrath A; Toneff MJ; Bogoslovskaia E; Zhang X; Moraes RC; Fluck M; Allred DC; Lewis MT; Varmus HE; Li Y Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17396-401. PubMed ID: 17090666 [TBL] [Abstract][Full Text] [Related]
13. Metastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markers. Weng D; Penzner JH; Song B; Koido S; Calderwood SK; Gong J Breast Cancer Res; 2012 Jan; 14(1):R18. PubMed ID: 22277639 [TBL] [Abstract][Full Text] [Related]
14. P190B RhoGAP has pro-tumorigenic functions during MMTV-Neu mammary tumorigenesis and metastasis. McHenry PR; Sears JC; Herrick MP; Chang P; Heckman-Stoddard BM; Rybarczyk M; Chodosh LA; Gunther EJ; Hilsenbeck SG; Rosen JM; Vargo-Gogola T Breast Cancer Res; 2010; 12(5):R73. PubMed ID: 20860838 [TBL] [Abstract][Full Text] [Related]
16. MMTV-PyMT and Derived Met-1 Mouse Mammary Tumor Cells as Models for Studying the Role of the Androgen Receptor in Triple-Negative Breast Cancer Progression. Christenson JL; Butterfield KT; Spoelstra NS; Norris JD; Josan JS; Pollock JA; McDonnell DP; Katzenellenbogen BS; Katzenellenbogen JA; Richer JK Horm Cancer; 2017 Apr; 8(2):69-77. PubMed ID: 28194662 [TBL] [Abstract][Full Text] [Related]
17. Impairment of mammary lobular development induced by expression of TGFbeta1 under the control of WAP promoter does not suppress tumorigenesis in MMTV-infected transgenic mice. Buggiano V; Schere-Levy C; Abe K; Vanzulli S; Piazzon I; Smith GH; Kordon EC Int J Cancer; 2001 May; 92(4):568-76. PubMed ID: 11304693 [TBL] [Abstract][Full Text] [Related]
18. MRCKα Is Dispensable for Breast Cancer Development in the MMTV-PyMT Model. Kwa MQ; Brandao R; Phung TH; Ge J; Scieri G; Brakebusch C Cells; 2021 Apr; 10(4):. PubMed ID: 33921698 [TBL] [Abstract][Full Text] [Related]
19. Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease. Qiu TH; Chandramouli GV; Hunter KW; Alkharouf NW; Green JE; Liu ET Cancer Res; 2004 Sep; 64(17):5973-81. PubMed ID: 15342376 [TBL] [Abstract][Full Text] [Related]
20. Knockout model reveals the role of Nischarin in mammary gland development, breast tumorigenesis and response to metformin treatment. Dong S; Ruiz-Calderon B; Rathinam R; Eastlack S; Maziveyi M; Alahari SK Int J Cancer; 2020 May; 146(9):2576-2587. PubMed ID: 31525254 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]